The role of FoxO4 in the relationship between alcohol-induced intestinal barrier dysfunction and liver injury

Chang,Bing; Sang,Lixuan; Wang,Ying; Tong,Jing; Wang,Bingyuan

doi:10.3892/ijmm.2013.1229

The role of FoxO4 in the relationship between alcohol-induced intestinal barrier dysfunction and liver injury

Authors:
- Bing Chang
- Lixuan Sang
- Ying Wang
- Jing Tong
- Bingyuan Wang
View Affiliations

Affiliations: Department of Gastroenterology, The First Afﬁliated Hospital of China Medical University, Shenyang, Liaoning 110001, P.R. China, Department of Cadre Ward II, The First Afﬁliated Hospital of China Medical University, Shenyang, Liaoning 110001, P.R. China
Published online on: January 4, 2013 https://doi.org/10.3892/ijmm.2013.1229
Pages: 569-576

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Forkhead box ‘Other’ (FoxO) proteins, a subgroup of the Forkhead transcription factor family, play an important role in mediating the effects of insulin and growth factors on diverse physiological functions. In this study, we investigated the role of FoxO4 in the relationship between alcohol liver disease and intestinal barrier dysfunction using an animal model. Six to eight-week-old male WT rats were divided into eight groups. They were separately administered corn starch dissolved in PBS; 40% alcohol (5 g/kg body weight) through stomach feeding every 12 h/time, three times in total; tumor necrosis factor α (TNFα) (10 µg/kg) injected intraperitoneally 30 min before alcohol administration; wortmannin (1.4 mg/kg) 30 min before alcohol administration; IGF-1 (0.2 mg/kg) 30 min before alcohol administration; anti-TNFα (5 mg/kg) injected intravenously 30 min before alcohol administration. In addition, two placebo groups were treated with PBS either intraperitoneally or intravenously prior to alcohol administration. TNFα and endotoxin in plasma were measured by ELISA and Tachypleus Amebocye Lysate assays. Immunohistochemistry and western blotting were used to identify the mechanisms of FoxO4 action in regulating epithelial permeability. Furthermore, electron microscopy, reverse transcription-polymerase chain reaction and western blotting were used to examine the expression of tight junction proteins and nuclear factor-κB (NF-κB). Compared with the control group, TNFα in the alcohol group was significantly higher. TNFα could induce FoxO4 phosphorylation; p-FoxO4 was limited into the cytoplasm and inactivated; inactive FoxO4 which was in high levels lost the ability to suppress NF-κB. Therefore, the expression of NF-κB was increased and it downregulated tight junction protein (including ZO-1 and occludin) expression, and increased epithelial permeability. As a result, intestinal bacteria grew excessively, endotoxin was released into the portal circulation and liver injury deteriorated. These results indicate that a complex network of mechanisms is involved in the beneficial effects of FoxO4 in epithelial barrier dysfunction. TNFα can upregulate phosphorylation of FoxO4. FoxO4 which is located in the nucleus is limited into the cytoplasm and inactivated; it loses the ability to suppress NF-κB activity, it downregulates the expression of tight junction proteins and increases epithelial permeability. Disruption of the intestinal barrier allows endotoxin and other bacterial products in the gut lumen to pass into the portal circulation and cause hepatic inflammation. At the same time, the changes of liver injury deteriorate.

View Figures

View References

1	Stewart S, Jones D and Day CP: Alcoholic liver disease: new insights into mechanisms and preventative strategies. Trends Mol Med. 7:408–413. 2001. View Article : Google Scholar : PubMed/NCBI
2	Rouault TA: Hepatic iron overload in alcoholic liver disease: why does it occur and what is its role in pathogenesis? Alcohol. 30:103–106. 2003. View Article : Google Scholar : PubMed/NCBI
3	Keshavarzian A, Holmes EW, Patel M, et al: Leaky gut in alcoholic cirrhosis: a possible mechanism for alcohol-induced liver damage. Am J Gastroenterol. 94:200–207. 1999. View Article : Google Scholar : PubMed/NCBI
4	Ma TY, Iwamoto GK, Hoa NT, et al: TNF-alpha-induced increase in intestinal epithelial tight junction permeability requires NF-kappa B activation. Am J Physiol Gastrointest Liver Physiol. 286:G367–G376. 2004. View Article : Google Scholar : PubMed/NCBI
5	Ma TY and Anderson JM: Tight junctions and intestinal barrier. Physiology of the Gastrointestinal Tract. LR Johnson: Elsevier Academic Press; New York, NY: pp. 1559–1594. 2006
6	Marchetti V, Menghini R, Rizza S, et al: Benfotiamine counteracts glucose toxicity effects on endothelial progenitor cell differentiation via Akt/FoxO signaling. Diabetes. 55:2231–2237. 2006. View Article : Google Scholar : PubMed/NCBI
7	Essaghir A, Dif N, Marbehant CY, et al: The transcription of FOXO genes is stimulated by FOXO3 and repressed by growth factors. J Biol Chem. 284:10334–10342. 2009. View Article : Google Scholar : PubMed/NCBI
8	Liu ZP, Wang Z, Yanagisawa H and Olson EN: Phenotypic modulation of smooth muscle cells through interaction of FoxO4 and myocardin. Dev Cell. 9:261–270. 2005. View Article : Google Scholar : PubMed/NCBI
9	Burgering BM: A brief introduction to FOXOlogy. Oncogene. 27:2258–2262. 2008. View Article : Google Scholar : PubMed/NCBI
10	Lin L, Hron JD and Peng SL: Regulation of NF-kappaB, Th activation and autoinflammation by the forkhead transcription factor Foxo3a. Immunity. 21:203–213. 2004. View Article : Google Scholar : PubMed/NCBI
11	Dengler HS, Baracho GV, Omori SA, et al: Distinct functions for the transcription factor Foxo1 at various stages of B cell differentiation. Nat Immunol. 9:1388–1398. 2008. View Article : Google Scholar : PubMed/NCBI
12	Paik JH, Kollipara R, Chu G, et al: FoxOs are lineage-restricted redundant tumor suppressors and regulate endothelial cell homeostasis. Cell. 128:309–323. 2007. View Article : Google Scholar : PubMed/NCBI
13	Tothova Z, Kollipara R, Huntly BJ, et al: FoxOs are critical mediators of hematopoietic stem cell resistance to physiologic oxidative stress. Cell. 128:325–339. 2007. View Article : Google Scholar : PubMed/NCBI
14	Birkenkamp KU and Coffer PJ: Regulation of cell survival and proliferation by the FOXO (Forkhead box, class O) subfamily of Forkhead transcription factors. Biochem Soc Trans. 31:292–297. 2003. View Article : Google Scholar : PubMed/NCBI
15	Lüpertz R, Chovolou Y, Unfried K, et al: The forkhead transcription factor FOXO4 sensitizes cancer cells to doxorubicin-mediated cytotoxicity. Carcinogenesis. 29:2045–2052. 2008.PubMed/NCBI
16	Matsuzaki H, Ichino A, Hayashi T, et al: Regulation of intracellular localization and transcriptional activity of FOXO4 by protein kinase B through phosphorylation at the motif sites conserved among the FOXO family. J Biochem. 138:485–491. 2005. View Article : Google Scholar
17	Anderson RC, Cookson AL, McNabb WC, et al: Lactobacillus plantarum MB452 enhances the function of the intestinal barrier by increasing the expression levels of genes involved in tight junction formation. BMC Microbiol. 10:3162010. View Article : Google Scholar
18	Donato KA, Gareau MG, Wang YJ and Sherman PM: Lactobacillus rhamnosus GG attenuates interferon-(gamma) and tumour necrosis factor-alpha-induced barrier dysfunction and pro-inflammatory signalling. Microbiology. 156:3288–3297. 2010. View Article : Google Scholar : PubMed/NCBI
19	Ewaschuk JB, Diaz H, Meddings L, et al: Secreted bioactive factors from Bifidobacterium infantis enhance epithelial cell barrier function. Am J Physiol Gastrointest Liver Physiol. 295:G1025–G1034. 2008.PubMed/NCBI
20	Karczewski J, Troost FJ, Konings I, et al: Regulation of human epithelial tight junction proteins by Lactobacillus plantarum in vivo and protective effects on the epithelial barrier. Am J Physiol Gastrointest Liver Physiol. 298:G851–G859. 2010. View Article : Google Scholar : PubMed/NCBI
21	Mennigen R, Nolte K, Rijcken E, et al: Probiotic mixture VSL#3 protects the epithelial barrier by maintaining tight junction protein expression and preventing apoptosis in a murine model of colitis. Am J Physiol Gastrointest Liver Physiol. 296:G1140–G1149. 2009.
22	Resta-Lenert S and Barrett KE: Live probiotics protect intestinal epithelial cells from the effects of infection with enteroinvasive Escherichia coli (EIEC). Gut. 52:988–997. 2003. View Article : Google Scholar : PubMed/NCBI
23	Zyrek AA, Cichon C, Helms S, et al: Molecular mechanisms underlying the probiotic effects of Escherichia coli Nissle 1917 involve ZO-2 and PKCzeta redistribution resulting in tight junction and epithelial barrier repair. Cell Microbiol. 9:804–816. 2007.PubMed/NCBI
24	Ye D, Ma I and Ma TY: Molecular mechanism of tumor necrosis factor-alpha modulation of intestinal epithelial tight junction barrier. Am J Physiol Gastrointest Liver Physiol. 290:G496–G504. 2006. View Article : Google Scholar : PubMed/NCBI
25	Atreya I, Atreya R and Neurath MF: NF-kappaB in inflammatory bowel disease. J Intern Med. 263:591–596. 2008. View Article : Google Scholar : PubMed/NCBI
26	Zhou W, Cao Q, Peng Y, Zhang QJ, et al: FoxO4 inhibits NF-kappaB and protects mice against colonic injury and inflammation. Gastroenterology. 137:1403–1414. 2009. View Article : Google Scholar : PubMed/NCBI
27	Andresen L, Jørgensen VL, Perner A, et al: Activation of nuclear factor kappaB in colonic mucosa from patients with collagenous and ulcerative colitis. Gut. 54:503–509. 2005. View Article : Google Scholar : PubMed/NCBI
28	Montufar-Solis D, Garza T and Klein JR: T-cell activation in the intestinal mucosa. Immunol Rev. 215:189–201. 2007. View Article : Google Scholar : PubMed/NCBI
29	Gadjeva M, Wang Y and Horwitz BH: NF-kappaB p50 and p65 subunits control intestinal homeostasis. Eur J Immunol. 37:2509–2517. 2007. View Article : Google Scholar : PubMed/NCBI
30	Nenci A, Becker C, Wullaert A, et al: Epithelial NEMO links innate immunity to chronic intestinal inflammation. Nature. 446:557–561. 2007. View Article : Google Scholar : PubMed/NCBI